Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3874460 | The Journal of Urology | 2006 | 8 Pages |
Abstract
Hemostatic agent use is promising and yet unproven for most conditions currently treated in urology. Hemostasis continues to be the main indication, which is well established. Few trials have examined comparative efficacy among hemostatic agents and further prospective studies are needed to justify additional indications as well as determine the optimal mode of use. Minimally invasive surgery will further drive the use of hemostatic agents and sealants. Cost-effective, evidence based hemostatic agent use will continue to challenge all urologists.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Y. Mark Hong, Kevin R. Loughlin,